9-108856646-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The variant allele was found at a frequency of 0.471 in 166,928 control chromosomes in the GnomAD database, including 19,318 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.46 ( 16922 hom., cov: 32)
Exomes 𝑓: 0.56 ( 2396 hom. )
Consequence
Unknown
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.107
Publications
2 publications found
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.515 is higher than 0.05.
Variant Effect in Transcripts
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
There are no transcript annotations for this variant. | |||||||||
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
There are no transcript annotations for this variant. | |||||||||
Frequencies
GnomAD3 genomes AF: 0.462 AC: 70153AN: 151808Hom.: 16910 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
70153
AN:
151808
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.561 AC: 8414AN: 15002Hom.: 2396 Cov.: 0 AF XY: 0.562 AC XY: 4020AN XY: 7148 show subpopulations
GnomAD4 exome
AF:
AC:
8414
AN:
15002
Hom.:
Cov.:
0
AF XY:
AC XY:
4020
AN XY:
7148
show subpopulations
African (AFR)
AF:
AC:
3
AN:
6
American (AMR)
AF:
AC:
2
AN:
4
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
AC:
6
AN:
8
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
8259
AN:
14710
Middle Eastern (MID)
AF:
AC:
1
AN:
2
European-Non Finnish (NFE)
AF:
AC:
80
AN:
160
Other (OTH)
AF:
AC:
63
AN:
112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
234
468
703
937
1171
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.462 AC: 70188AN: 151926Hom.: 16922 Cov.: 32 AF XY: 0.465 AC XY: 34498AN XY: 74240 show subpopulations
GnomAD4 genome
AF:
AC:
70188
AN:
151926
Hom.:
Cov.:
32
AF XY:
AC XY:
34498
AN XY:
74240
show subpopulations
African (AFR)
AF:
AC:
14140
AN:
41440
American (AMR)
AF:
AC:
6560
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
1797
AN:
3466
East Asian (EAS)
AF:
AC:
2555
AN:
5134
South Asian (SAS)
AF:
AC:
2133
AN:
4810
European-Finnish (FIN)
AF:
AC:
6029
AN:
10550
Middle Eastern (MID)
AF:
AC:
120
AN:
292
European-Non Finnish (NFE)
AF:
AC:
35288
AN:
67938
Other (OTH)
AF:
AC:
962
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1884
3767
5651
7534
9418
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
648
1296
1944
2592
3240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1664
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.